Tamoxifen modulates apoptosis in multiple modes of action in CreER mice

Genesis (New York, N.Y. : 2000)
|December 24, 2008
PubMed

Insights

Tamoxifen has dual effects on embryonic apoptosis. Olig2-CreER mice show tamoxifen-induced toxicity in the neural tube but cytoprotection in dorsal root ganglia, impacting genome manipulation studies.

Area of Science:

  • Developmental Biology
  • Genetics
  • Molecular Biology

Background:

  • Tamoxifen-inducible Cre (CreER) systems are vital for in vivo genetic manipulation.
  • Investigating the complex roles of tamoxifen in embryonic development is crucial for understanding CreER system applications.

Discussion:

  • Tamoxifen exhibits opposing effects on apoptosis during embryogenesis in Olig2-CreER mice.
  • CreER-mediated toxicity induces region-specific apoptosis in the ventral neural tube of homozygous mice.
  • Tamoxifen independently confers a cytoprotective effect on apoptosis in dorsal root ganglia (DRG).

Key Insights:

  • The cytoprotective effect in DRG is specific and not a direct result of Olig2/CreER expression.
  • Tamoxifen's dual actions necessitate careful interpretation of results from tamoxifen-induced recombination experiments.
  • Olig2-CreER heterozygotes are suitable for lineage tracing with minimal toxicity, while homozygotes exhibit efficient recombination but increased apoptosis.

Outlook:

  • Further research is needed to elucidate the precise mechanisms behind tamoxifen's dual apoptotic effects.
  • Optimizing tamoxifen dosage and timing is essential for reliable genetic manipulation using CreER systems.
  • These findings have implications for designing safer and more effective gene-editing strategies in developmental studies.